rs145081583

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_012186.3(FOXE3):​c.423G>A​(p.Lys141Lys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00166 in 1,609,320 control chromosomes in the GnomAD database, including 46 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0092 ( 29 hom., cov: 32)
Exomes 𝑓: 0.00088 ( 17 hom. )

Consequence

FOXE3
NM_012186.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 0.517

Publications

1 publications found
Variant links:
Genes affected
FOXE3 (HGNC:3808): (forkhead box E3) This intronless gene belongs to the forkhead family of transcription factors, which is characterized by a distinct forkhead domain. The protein encoded functions as a lens-specific transcription factor and plays an important role in vertebrate lens formation. Mutations in this gene are associated with anterior segment mesenchymal dysgenesis and congenital primary aphakia. [provided by RefSeq, Dec 2009]
LINC01389 (HGNC:50661): (long intergenic non-protein coding RNA 1389)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.51).
BP6
Variant 1-47416738-G-A is Benign according to our data. Variant chr1-47416738-G-A is described in ClinVar as Benign. ClinVar VariationId is 260211.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.517 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0092 (1387/150690) while in subpopulation AFR AF = 0.0324 (1341/41428). AF 95% confidence interval is 0.0309. There are 29 homozygotes in GnomAd4. There are 626 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 29 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FOXE3NM_012186.3 linkc.423G>A p.Lys141Lys synonymous_variant Exon 1 of 1 ENST00000335071.4 NP_036318.1
LINC01389NR_126355.1 linkn.29-6837C>T intron_variant Intron 1 of 4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FOXE3ENST00000335071.4 linkc.423G>A p.Lys141Lys synonymous_variant Exon 1 of 1 6 NM_012186.3 ENSP00000334472.2

Frequencies

GnomAD3 genomes
AF:
0.00918
AC:
1382
AN:
150582
Hom.:
28
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0323
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00218
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000444
Gnomad OTH
AF:
0.00434
GnomAD2 exomes
AF:
0.00230
AC:
573
AN:
249146
AF XY:
0.00150
show subpopulations
Gnomad AFR exome
AF:
0.0327
Gnomad AMR exome
AF:
0.00115
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000354
Gnomad OTH exome
AF:
0.000993
GnomAD4 exome
AF:
0.000884
AC:
1289
AN:
1458630
Hom.:
17
Cov.:
33
AF XY:
0.000717
AC XY:
520
AN XY:
725700
show subpopulations
African (AFR)
AF:
0.0329
AC:
1097
AN:
33296
American (AMR)
AF:
0.00131
AC:
58
AN:
44388
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26030
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39496
South Asian (SAS)
AF:
0.0000930
AC:
8
AN:
85980
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53352
Middle Eastern (MID)
AF:
0.000353
AC:
2
AN:
5672
European-Non Finnish (NFE)
AF:
0.00000540
AC:
6
AN:
1110198
Other (OTH)
AF:
0.00196
AC:
118
AN:
60218
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
79
157
236
314
393
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00920
AC:
1387
AN:
150690
Hom.:
29
Cov.:
32
AF XY:
0.00850
AC XY:
626
AN XY:
73634
show subpopulations
African (AFR)
AF:
0.0324
AC:
1341
AN:
41428
American (AMR)
AF:
0.00217
AC:
33
AN:
15182
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3454
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5162
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
9788
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.0000444
AC:
3
AN:
67542
Other (OTH)
AF:
0.00429
AC:
9
AN:
2096
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
70
139
209
278
348
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00506
Hom.:
5
Bravo
AF:
0.0104
EpiCase
AF:
0.00
EpiControl
AF:
0.000119

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Apr 12, 2016
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jul 21, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

not provided Benign:2
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Mar 12, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Congenital primary aphakia;C1862839:Anterior segment dysgenesis Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Cardiovascular phenotype Benign:1
Apr 29, 2019
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.51
CADD
Benign
10
DANN
Benign
0.96
PhyloP100
0.52
PromoterAI
0.0082
Neutral
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs145081583; hg19: chr1-47882410; API